Početna › Srpasto stanica › Virginia
Kliničke studije za Srpasto stanica u državi Virginia
9 studija za Srpasto stanica traži sudionike na lokacijama u državi Virginia.
Gradovi u državi Virginia
Službeni tekst studije (engleski)
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Inova Health System, Fairfax
- Children's Hsptl Of The Kings, Norfolk
- Virginia Comm Univ Medical Ctr, Richmond
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT06612268Early Screening and Treatment of Heart Complication in Sickle Cell Disease
- Inova Schar Cancer, Fairfax
- Inova Health Care Service, Falls Church
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07023666A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Inova Schar Cancer Institute, Fairfax
- Virginia Commonwealth University (VCU) Medical Center, Richmond
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Inova Schar Cancer Institute, Fairfax
U tijeku regrutacijaFaza 2/3
Od 12 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Kings Daughters, Norfolk
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 17. kol 2026. · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Virginia Commonwealth University, Richmond
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Virginia Commonwealth University, Richmond
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- VCU Massey Cancer Center: Dalton Oncology Clinic- Site Number : 8400012, Richmond
U tijeku regrutacijaFaza 3
Od 10 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06975865Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Virginia Commonwealth University, Richmond
U tijeku regrutacija
Od 16 do 30 godina · Oba spola · Ažurirano 7. sij 2026. · NCT06374238Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.